Introduction: The current literature suggests hyperglycemia can predict poor outcomes in patients with primary intracerebral hemorrhage (ICH). Chronic hyperglycemia is seen in patients with pre-existing diabetes (DM); however, acute hyperglycemia in non-diabetic patients is defined as stress-induced hyperglycemia (SIH). This study explored the influence of hyperglycemia on outcomes of primary ICH patients both in the presence and absence of pre-existing DM. Methods: Data regarding admission glucose, pre-existing DM, inpatient mortality, and modified Rankin Scale (mRS) scores at discharge were available for 636 patients admitted to Stony Brook Hospital from January 2011 to December 2022 with a primary diagnosis of ICH. Regression models were used to compare outcomes between patients with admission hyperglycemia and/or pre-existing DM to a control group of normoglycemic and non-diabetic ICH patients. Results: Patients with SIH had higher inpatient mortality rates and worse mRS scores at discharge (p < 0.001). An association with higher mortality and worse mRS scores at discharge was also seen in patients with hyperglycemia secondary to DM, although the strength of this association was weaker when compared to patients with SIH. Conclusions: Our findings suggest that SIH may play a greater role in predicting poor outcomes at discharge rather than a history of poorly controlled DM with chronic hyperglycemia. To develop a more thorough understanding of this topic, prospective studies evaluating the effect of changes in serum glucose during hospital stay on short and long-term outcomes is needed.
3 October 2025 in Surgical Neurology International
Background: Enhanced recovery after surgery (ERAS) protocols are standardized procedural guidelines proven to decrease hospital stay and postoperative narcotic use and improve overall patient experience. There is no existing ERAS protocol for open cranial vault remodeling (CVR) in the pediatric population. We believe that CVR is one such surgery meriting an ERAS protocol given its multidisciplinary and longitudinal treatment course. Such protocol is of particular interest in San Bernardino County, where the vast geographic area and wide socioeconomic spectrum result in unique barriers to healthcare accessibility that favor open remodeling over endoscopic approaches. Methods: The primary purpose of an ERAS protocol is to minimize both psychological and physiologic stress associated with a given procedure. This can be targeted at various phases of the patient encounter, including the preoperative, intraoperative, and postoperative stages. Here, we introduce our pilot protocol for ERAS implemented at Loma Linda University Children’s Hospital (LLUCH) starting since 2018. Results: Our CVR process begins at the craniofacial clinic, where interdisciplinary chart and imaging review ensure appropriate patient enrollment and clinical service engagement. Day of surgery checklists ensure standardized preoperative cleansing, fasting, and laboratory criteria. Intraoperative guidelines facilitate interdisciplinary transparency regarding antibiotics, blood transfusions, fluid status, pain control, and tranexamic acid and mannitol administration. Standardized postoperative criteria dictate progression through the intensive care unit through to discharge. Conclusion: Retrospective chart review will compare LLUCH outcomes to those reflected in the National Surgical Quality Improvement Program. We hope to demonstrate that the CVR process at LLUCH is comparable to the national average and that implementation of a standardized ERAS protocol can significantly improve clinical and social outcomes.
BACKGROUND AND OBJECTIVES: Implanted neuromodulatory devices can be threatened by thin overlying tissue and refractory device-associated pain, both of which present significant clinical challenges with few reliable management strategies. We describe the technical workflow and preliminary clinical outcomes of autologous fat graft (AFG) for the management of neuromodulation device-related pain and dermal erosion. METHODS: This retrospective single-center technical case series details the indications, operative technique, and early postoperative results in 2 patients treated with a novel application of a standard plastic surgery technique in the context of functional neurosurgery. Autologous fat was harvested from patient donor sites and applied around a spinal cord stimulator to alleviate pain in one case and around a deep brain stimulation electrode to prevent dermal erosion in the other. Patients were followed for a minimum of 1 month of postoperative care. RESULTS: In both cases, AFG successfully addressed the hardware-related complication without requiring complete device revision. The first patient experienced substantial and durable pain reduction for 2 years before requiring repeat grafting due to progressive graft resorption. In the second case, improved scalp thickness prevented progression of early erosion, although mild thinning was noted at 1 month. No perioperative complications occurred in either case. CONCLUSION: This early technical experience demonstrates that AFG is feasible, well-tolerated, and may provide meaningful symptomatic and reconstructive benefit as a minimally invasive adjunct in neuromodulation surgery. Longer-term prospective evaluation is required before definitive conclusions regarding durability and clinical efficacy can be drawn.